Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
DALLAS, March 16, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG), a leading Bitcoin…
VitalHub Reports Fourth Quarter 2025 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up…
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the…
Hybrid Software Group PLC reports 2025 results with 17% increase in adjusted operating profit and 252% increase in net cash
PRESS RELEASE – REGULATED INFORMATION HYBRID SOFTWARE GROUP PLC REPORTS 2025 RESULTS…
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
March 08, 2026 14:00 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Presented positive updated data from the ALLOHA™ Phase 1 heme trial at…
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00…
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated…
THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS
Strong share gains and solid growth; operating leverage and cashflow drive deleveragingZURICH,…
